Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Achieve Life Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ACHV
Nasdaq
8731
http://achievelifesciences.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Achieve Life Sciences Inc
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
- Apr 11th, 2024 12:00 pm
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript
- Apr 1st, 2024 7:30 pm
ACHV: 2023 Results
- Apr 1st, 2024 9:44 am
Q4 2023 Achieve Life Sciences Inc Earnings Call
- Mar 29th, 2024 10:24 am
Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval
- Mar 28th, 2024 9:32 pm
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
- Mar 28th, 2024 8:01 pm
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
- Mar 20th, 2024 12:00 pm
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
- Mar 14th, 2024 12:00 pm
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
- Mar 8th, 2024 1:35 pm
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
- Mar 6th, 2024 1:00 pm
Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
- Mar 5th, 2024 1:35 pm
ACHV: ORCA-OL to Start 2Q:24
- Mar 1st, 2024 9:10 am
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
- Feb 29th, 2024 1:01 pm
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
- Feb 29th, 2024 1:00 pm
Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap touched US$109m last week, benefiting both retail investors who own 59% as well as institutions
- Jan 27th, 2024 12:13 pm
ACHV: Not So Fast…
- Dec 18th, 2023 9:15 am
Life Science Investor Forum: Presentations Now Available for Online Viewing
- Dec 15th, 2023 1:35 pm
TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
- Dec 13th, 2023 1:00 pm
Life Science Investor Forum Agenda Announced for December 14th, 2023
- Dec 12th, 2023 6:02 pm
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call Transcript
- Nov 11th, 2023 3:36 pm
Scroll